Evidence map›Paper›PMID 21907838›Full record

ReviewBone2011

Genetic mouse models for bone studies--strengths and limitations.

Florent Elefteriou, Xiangli Yang

Abstract readReview
In one paragraph

Review in Bone, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Molecular Basis of Fracture Pseudarthrosis Associated with Neurofibromatosis Type 1.Journal of the Pediatric Orthopaedic Society of North America · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. KLF transcription factors in bone diseases.Journal of cellular and molecular medicine · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. An Update on Animal Models of Osteogenesis Imperfecta.Calcified tissue international · 2022
    Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Florent ElefteriouVanderbilt University Medical Center, Department of Medicine, Vanderbilt Center for Bone Biology, Nashville, TN 37232-0575, USA. florent.elefteriou@vanderbilt.edu
Xiangli Yang

Funding

Transcriptional Regulation of Indian Hedgehog Expression in ChondrocytesR01AR055972 · NIAMS · VANDERBILT UNIVERSITY · PI YANG, XIANGLI · 2008 to 2012
$1.7M
NIAMS NIH HHS R01 AR055972
6 · The paper itself

Abstract

Mice have become a preferred model system for bone research because of their genetic and pathophysiological similarities to humans: a relatively short reproductive period, leading to relatively low cost of maintenance and the availability of the entire mouse genome sequence information. The success in producing the first transgenic mouse line that expressed rabbit β-globin protein in mouse erythrocytes three decades ago marked the beginning of the use of genetically engineered mice as model system to study human diseases. Soon afterward the development of cultured pluripotent embryonic stem cells provided the possibility of gene replacement or gene deletion in mice. These technologies have been critical to identify new genes involved in bone development, growth, remodeling, repair, and diseases, but like many other approaches, they have limitations. This review will introduce the approaches that allow the generation of transgenic mice and global or conditional (tissue-specific and inducible) mutant mice. A list of the various promoters used to achieve bone-specific gene deletion or overexpression is included. The limitations of these approaches are discussed, and general guidelines related to the analysis of genetic mouse models are provided.

Indexed as

Models, AnimalAnimalsBone and BonesGene DeletionGene TargetingMiceMice, TransgenicPromoter Regions, GeneticTransgenes

Identifiers

PMID21907838
PMCPMC3331798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.